News

Serve You Rx Launches Biosimilar Advantage Formulary to Provide Lower Upfront Cost Options for Specialty Drugs

New Formulary Strategy Advances Biosimilar Adoption and AffordabilityMILWAUKEE, WI / ACCESSWIRE / June 12, 2024 / Serve You Rx, a…

2 years ago

SFWJ/MedCana Announces Strategic Partnership with Colombian Company to Begin Exporting CBD Buds to Switzerland

AUSTIN, TX / ACCESSWIRE / June 12, 2024 / SFWJ, doing business as Medcana, a holding company focused in the…

2 years ago

How Luciana Preger Is Helping Advance Gilead’s Work in Oncology

NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Gilead SciencesLuciana Preger credits being exposed to her father's work at…

2 years ago

Nava Health Begins Construction on First Boston-Area Location; New Center in Chestnut Hill Will Provide Personalized Functional and Longevity Medicine

CHESTNUT HILL, MA / ACCESSWIRE / June 12, 2024 / Nava Health, a leader in longevity, integrative, and functional medicine,…

2 years ago

Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024

Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar…

2 years ago

Clearstep Unveils Advanced Self-Service Booking for Specialist Care

New AI-driven technology integration marks a first in the U.S., enhancing patient access to specialized care and streamlining complex scheduling…

2 years ago

Rutherrin(R) Increases Efficacy of Chemotherapy

TORONTO, ON / ACCESSWIRE / June 12, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

2 years ago

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches Surrozen’s current SWEETS bispecific antibodies are…

2 years ago

Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical…

2 years ago